Kevin Lee Freeman - Sep 3, 2024 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Role: Chief Commercial Officer
Signature: /s/Benjamin Landry, as Attorney-in-Fact
Stock symbol: HCAT
Transactions as of: Sep 3, 2024
Transactions value $: -$74,324
Form type: 4
Date filed: 9/5/2024, 04:42 PM
Previous filing: Jun 12, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCAT	Common Stock	Tax liability	-$20.1K	-2.77K	-1.04%	$7.27	263K	Sep 3, 2024	Direct	F1
transaction	HCAT	Common Stock	Sale	-$54.2K	-7.5K	-2.85%	$7.22	256K	Sep 3, 2024	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
F2	The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 12, 2024 in accordance with Rule 10b5-1.

Content

Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 12, 2024 in accordance with Rule 10b5-1.